Quick Answer
Medtronic plc reported Diluted EPS of $3.61 per share for fiscal year 2025.
Medtronic plc Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $3.61 | +30.8% |
| 2024 | $2.76 | -2.1% |
| 2023 | $2.82 | -24.4% |
| 2022 | $3.73 | +40.2% |
| 2021 | $2.66 | -24.9% |
| 2020 | $3.54 | +3.8% |
| 2019 | $3.41 | +50.2% |
| 2018 | $2.27 | -21.5% |
| 2017 | $2.89 | +16.5% |
| 2016 | $2.48 | +2.9% |
| 2015 | $2.41 | -20.2% |
| 2014 | $3.02 | -10.4% |
| 2013 | $3.37 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $0.89 | -11.9% | -16.8% |
| October 31, 2025 | $1.07 | +8.1% | +32.1% |
| July 31, 2025 | $0.81 | +1.3% | -19.8% |
| January 31, 2025 | $1.01 | +2.0% | +2.0% |
| October 31, 2024 | $0.99 | +45.6% | +23.7% |
| July 31, 2024 | $0.80 | +35.6% | -19.2% |
| January 31, 2024 | $0.99 | +7.6% | +45.6% |
| October 31, 2023 | $0.68 | +112.5% | +15.3% |
- Medtronic plc showed an increase of +30.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2013–2025 period, Medtronic plc’s diluted eps has grown by 7.1% (from $3.37 per share to $3.61 per share).
- The most recent figure is from Medtronic plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on June 20, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: